MACALLISTER; Thomas

Patent Applications and Registrations

Patent applications and USPTO patent grants for MACALLISTER; Thomas.The latest application filed is for "methods of treating 4-repeat tauopathies".

Company Profile

1.4.16

MACALLISTER; Thomas - Arlington VA
Macallister; Thomas - New York NY
MacAllister; Thomas - McLean VA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods Of Treating 4-repeat Tauopathies App 20220125799 - MACALLISTER; Thomas ; et al.	2022-04-28
Methods of treating 4-repeat tauopathies Grant 11,311,553 - MacAllister , et al. April 26, 2	2022-04-26
Methods of medical treatment with SUR1-TRPM4 channel inhibitors Grant 11,304,963 - Jacobson , et al. April 19, 2	2022-04-19
Methods Of Medical Treatment With Sur1-trpm4 Channel Inhibitors App 20220088039 - JACOBSON; Sven ; et al.	2022-03-24
Methods Of Treating Neurodevelopmental Disorders App 20220047607 - MACALLISTER; Thomas ; et al.	2022-02-17
Methods Of Treating Neurodevelopmental Disorders App 20210401853 - MACALLISTER; Thomas ; et al.	2021-12-30
Methods Of Treating Proteinopathy-associated Wandering App 20210299140 - MACALLISTER; Thomas ; et al.	2021-09-30
Method of Treating Ascites App 20210251943 - Jacobson; Sven ; et al.	2021-08-19
Methods Of Treating Cortical Dementia Associated Wandering App 20210213030 - MACALLISTER; Thomas ; et al.	2021-07-15
Stable Oral Liquid Formulation of Trimetazidine App 20210196707 - MacAllister; Thomas	2021-07-01
Stable oral liquid formulation of trimetazidine Grant 10,946,011 - MacAllister March 16, 2	2021-03-16
Use of Anti-Ischemic Compounds in Treating Acute-On-Chronic Liver Failure App 20200261443 - MacAllister; Thomas	2020-08-20
Stable Oral Liquid Formulation of Trimetazidine App 20190255039 - MacAllister; Thomas	2019-08-22
Methods Of Medical Treatment With Sur1-trpm4 Channel Inhibitors App 20190175624 - JACOBSON; Sven ; et al.	2019-06-13
Methods Of Treating Or Preventing Amyloid Related Imaging Abnormalities Associated With Alzheimer's Disease Treatment App 20190167611 - JACOBSON; Sven ; et al.	2019-06-06
Cloning, overexpression and therapeutic use of bioactive histidine ammonia lyase App 20060034817 - Roberts; Joseph ; et al.	2006-02-16
Cloning, overexpression and therapeutic use of bioactive histidine ammonia lyase Grant 6,939,541 - Roberts , et al. September 6, 2	2005-09-06
Cloning, overexpression and therapeutic use of bioactive histidine ammonia lyase App 20020052038 - Roberts, Joseph ; et al.	2002-05-02

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.